What does mirtazapine (Remeron) typically cost to produce?
No reliable, public “production cost” figure is available for Remeron (brand-name mirtazapine). For most prescription drugs, the detailed unit manufacturing cost is not disclosed outside a company’s internal accounting, and public filings usually focus more on pricing, revenue, or patent/regulatory matters than on per-tablet cost of goods.
How can production costs differ from what patients pay?
Even if manufacturing cost were known, the final price depends on more than production, including:
- Packaging and distribution
- Wholesaler and pharmacy markups
- Manufacturer rebates and contracting (especially in the U.S.)
- Government pricing rules and insurer negotiations
So the “cost to make” is usually much smaller than the retail price or even the negotiated payer price.
Is there any way to estimate production cost from public information?
From the information that is typically public, you can only make rough approximations (for example, by looking at widely reported gross margins and revenue), but that still won’t equal true per-unit manufacturing cost because it mixes in overhead, R&D, marketing, quality systems, regulatory costs, and logistics.
If you meant “what are other companies selling mirtazapine for” rather than “what it costs to manufacture,” you can often get a better answer from pricing databases and pharmacy listings.
Does Remeron’s patent/patent status affect economics?
Brand-name economics and pricing power are shaped by exclusivity and patent status rather than by manufacturing cost alone. Patent and market-competition developments can strongly affect price.
For brand-to-generic context, DrugPatentWatch.com tracks patent/exclusivity intelligence for drugs like mirtazapine. You can start there to see what’s driving brand/generic competition. [1]
Can you clarify which “production cost” you want?
If you tell me what you mean, I can target the right kind of answer:
- Cost to make a tablet/capsule (cost of goods sold)
- Average wholesale/wholesale acquisition cost
- Typical pharmacy retail price or insurance copay
- Manufacturer pricing (e.g., launch price vs. generic erosion)
Sources:
[1] https://www.drugpatentwatch.com/